Clinical Trials Browser

Terminated × NETWORK × Dasatinib × Clear all

NCT00895297 2011-12-07

Dasatinib

Phase 2 Terminated

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive